NEET MDS Lessons
Pharmacology
A. Sympathetic Nervous System Depressants
1. Antagonists
Both α-adrenoceptor antagonists and β-adrenoceptor antagonists are useful antihypertensives.
- α-blocker Prazosin, phentolamine, phenoxybenzamine
- β-blocker Propranolol ,Metoprolol, atenolol
- α/β-blocker labetalol
2. Sympathetic depressants
a. Examples of peripherally acting agents include
- reserpine This agent interferes with the storage of norepinephrine
- quanethidine This agent interferes with the release of norepinephrine
- trimethaphan This agent blocks transmission through autonomic ganglia.
b. Examples of Centrally acting agents include
- alphamethyldopa
- clonidine. These agents act by decreasing the number of impresses along sympathetic nerves.
Adverse Effect
include nasal congestion, postural hypotension, diarrhea, sexual dysfunction, dry mouth. sedation and drowsiness.
B. Directly Acting Vasodilators
Act on vascular smooth muscle cells independently of adrenergic nerves and adrenergic receptors.
Relaxation of vascular smooth muscle which leads to a decrease in peripheral vascular resistance.
Sites of action of vasodilators are many. For example
Calcium Channel Blocker’s MOA
. Decrease automaticity & conduction thru SA & AV nodes
. Decreased myocardial contractility
. Decreased peripheral & coronary
smooth muscle tone = decrease SVR
Potassium channels activators
minoxidil, cause vasodilation by activating potassium channels in vascular smooth muscle.
An increase in potassium conductance results in hyperpolarization of the cell membrane which is associated with relaxation of smooth muscle.
Nitrovasodilators, such as sodium nitroprusside,
Increase in intracellular cGMP. cGMP in turn activates a protein kinase. Directly-Acting Vasodilators are on occasion used alone but more frequently are used in combination with antihypertensive agents from other classes (esp. a β-blocker and a diuretic.)
Estimation of the risk of anesthesia (American Society of Anesthesiologists scale)
• ASA 1: healthy patient.
• ASA 2: patient with stable, treated illness like arterial hypertension, diabetes melitus, asthma bronchiale, obesity
• ASA 3: patient with systemic illness decreasing sufficiency like heart illness, late infarct
• ASA 4: patient with serious illness influencing his state like renal insuficiency, unstable hypertension, circulatory insuficiency
• ASA 5: patient in life treatening illness
• ASA 6: brain death- potential organ donor